| Literature DB >> 34825280 |
Massimo Del Fabbro1,2, Grazia Tommasato1, Paolo Pesce3, Andrea Ravidà4, Shahnawaz Khijmatgar1, Anton Sculean5, Matthew Galli4, Donato Antonacci6, Luigi Canullo7.
Abstract
AIM: By means of a systematic review and network meta-analysis, this study aims to answer the following questions: (a) does the placement of a biomaterial over an extraction socket lead to better outcomes in terms of horizontal and vertical alveolar dimensional changes and percentage of new bone formation than healing without coverage? And (b) which biomaterial(s) provide(s) the better outcomes?Entities:
Keywords: Alveolar ridge preservation; Coverage; Crosslinked membrane; Histomorphometric analysis; Network meta-analysis; Non-crosslinked membrane; Non-resorbable membrane; Resorbable membrane; Systematic review
Mesh:
Substances:
Year: 2021 PMID: 34825280 PMCID: PMC8816783 DOI: 10.1007/s00784-021-04262-3
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.573
Fig. 1Flowchart of the study selection process
Study included
| Author | Study design | Country | Sponsor | Intention healing | Flap/flapless | Buccal wall | Antibiotics | Smokers incl. Y/N | n. tooth patients treated | Material control | ctr material type/name | Membrane Y/N | Coverage ctr | Material test | test material type/name | Membrane Y/N | Coverage test | Outcomes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lim et al. [ | Parallel | South Korea | Y | Secondary | Flapless | Yes | Y | NR | 33 (21 included in this review)* | SH | Blood clot | N | No membrane | XG | T1. DBBM-C + NBCM T2. DBBM-C | T1:Y T2:N | T1: NBCM➔ Resorbable collagen membrane (NCL) | Vertical/horizontal change/vital bone |
| Mandarino et al. [ | Split-mouth | Brazil | N | First | Flap | Yes | Y | NR | 20 | SH | Blood clot | N | No membrane | SH | Blood clot | Y | Non-resorbable PTFE membrane | Soft tissue and hard tissue changes, vertical/horizontal change |
| Chang et al. [ | Parallel | Korea | Y | Secondary | Flapless | Yes | Y | NR | 42 | XG | DBBM-C | Y | Resorbable collagen membrane (Bio-Gide) (CL) | XG | DBBM-C | Y | Resorbable Collagen membrane (Lyso-Gide) (NCL) | Vertical/horizontal change Cast analysis and CBCT |
| Hassan et al. [ | Split-mouth | USA | Y | Secondary | Flap | Yes | NR | N | 9 | AG | FDBA + DFDBA | Y | Amnion-chorion membrane (ACM) | AG | FDBA + DFDBA | Y | Non-resorbable PTFE membrane | Vertical/horizontal change CBCT & histomorphometric analysis |
| Lim et al. [ | Parallel | Korea | N | First | Flap | Yes | Y | Y <20/d | 30 | XG | DBBM-C | Y | Collagen membrane (NCL) | XG | DBBM-C | Y | Collagen membrane (CL) | Vertical/horizontal change |
| Natto et al. [ | Parallel | Saudia | NR | Secondary | Flapless | Yes | NR | N | 28 | XG | Collagen sponge | Y | Resorbable collagen membrane | XG | Collagen matrix seal | Y | Resorbable collagen membrane (NCL) | Vertical/horizontal change |
| Arbab et al. [ | Parallel | USA | NR | Secondary | Flap | Yes | Y | Y | 24 | AG+XG | Cancellous AG + buccal overlay XG | Y | Resorbable collagen membrane (NCL) | AG+XG | Cancellous AG + buccal overlay XG | Y | Non-resorbable PTFE membrane | Vertical/horizontal change |
| Parashis et al. [ | Parallel | USA | NR | Secondary | Flap | Yes | Y | Y< 10/d | 23 | AG | FDBA | Y | Resorbable collagen membrane (NCL) | AG | FDBA | Y | extracellular resorbable collagen matrix membrane (NCL) | Vertical/horizontal change clinical & radiographic |
| Meloni et al. [ | Parallel | Italy | N | Secondary | Flapless | Yes | Y | Y <10/d | 30 | XG | DBBM | Y | CTG | XG | DBBM | Y | Porcine collagen matrix (NCL) | Vertical/horizontal change CBCT |
| Perelman et al. [ | Parallel | Israel | NR | First | Flap | Yes | N | N | 23 | XG | DBBM | N | No membrane | XG | DBBM | Y | Resorbable collagen membrane (CL) | Histomorphometric analysis |
| Engler-Hamm et al. [ | Split-mouth | USA | Y | First Vs Secondary | Flap | Yes | Y | N | 11 | XG+AG | ABM/P-15+DFDBA + primary closure | Y | polyglycolic acid and trimethylene carbonate copolymer membrane | XG+AG | ABM/P-15+DFDBA + secondary closure | Y | Polyglycolic acid and trimethylene carbonate copolymer membrane | Clinical healing, histology |
| Lekovic et al. [ | Split- mouth | Yugoslovia | NR | First | Flap | Yes | Y | NR | 16 | SH | Blood clot | Y | No membrane | SH | Blood clot | N | Resorbable membrane made of glycolide and lactide polymers | Clinical vertical/horizontal change (internal and external) |
Features of the study sample and outcomes for included studies
| Authors | M/F | Age (mean, SD, range) | Tooth type/location (A/P) | Arch (max/mand) | Follow-up, months | n.teeth ctr treated | n.teeth ctr evaluated | n.teeth test treated | n.teeth test evaluated | Main conclusions | Complications |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 16/5 | 54.36 +/− 9.91 (T1) 53.9 +/− 6.7 (T2) | Posterior (molar) | 13 maxilla/8 mandible | 4 | T2: 10 | T2: 10 | T1: 11 | T1: 10 | Alveolar ridge preservation without primary flap closure in molar areas is effective in minimizing ridge resorption. There were no significant differences between test groups in clinical and histomorphometric measurements | 0 | |
| 10/10 | 46.2 +/− 15.6 | Posterior | 20 mandible | 4 | 10 | 10 | 10 | 10 | Ridge preservation using the d-PTFE membrane increased the formation of keratinized tissue. The membrane had no influence on the healing process | 0 | |
| 20/22 | 60.0 +/− 10.0 (T) 60.5 +/− 11.6 (C) | NR | 21 maxilla/21 mandible | 6 | 21 | 21 | 21 | 21 | There were no significant differences between the ECM membranes in the changes in the dimension, width, and height of the extraction socket or the quantity of bone tissue | NR | |
| 6/3 | 34–71 (54.88) | Anterior & premolars | 14 maxilla/8 mandible | 3 | 11 | 11 | 11 | 11 | Intentionally exposed ACM is equally effective in ridge preservation compared to d-PTFE, however aid in reducing post-operative VAS scores and improved histomorphometric features | 0 | |
| 16/10 | 53.83 +/− 16.22 (T) 48.14 +/− 16.11 (C) | Anterior & premolars | Maxilla / mandible | 4 | 15 | 14 | 15 | 12 | The horizontal ridge alteration in ridge preservation did not differ significantly between using the non-cross linked and cross linked collagen membranes with collagenated bovine bone, but the vertical ridge alteration was more pronounced when using the cross linked membrane | Membrane exposure in the test group occurred in 47% and in the control group was 57% (8/14). Uneventful secondary healing was achieved in all cases | |
| 16/12 | 25 – 80 (55.4) | Single-rooted tooth (except lateral incisor) | 23 Maxilla/5 mandible | 4 | 14 | 14 | 14 | 14 | Collagen matrix seal and CS, when combined with FDBA, significantly minimized ridge resorption in all dimensions and maintained buccal soft tissue thickness in sockets, however there was no significant difference between both groups | NR | |
| 9/15 | 53 +/− 15 (CM) 52 +/− 15 (PTFE) | Anterior & premolars | 22 maxilla/2 mandible | 4 | 12 | 12 | 12 | 12 | No significant difference ( | 0 | |
| 12/11 | 35–65 (54.2) (CM) 36–68 (54.8) (ECM) | Incisors & premolars | 21 maxilla/2 mandible | 4 | 11 | 11 | 12 | 12 | No significant differences were observed between CM and ECM group in clinical and radiographical soft tissue and hard tissue changes. However, significant correlations for changes in gingival thickness ( | 1 pt in the CM group presented post-surgical infection with exfoliation of the graft | |
| 12/18 | 26–72 (48) | Anterior | Maxilla | 12 | 15 | 15 | 15 | 15 | Significant correlations for changes in gingival thickness ( | 0 | |
| 7/16 | 26–68 | Single-rooted tooth | 18 Maxilla/5 mandible | 9 | 11 | 11 | 13 | 12 | Bone area fraction was found significantly higher in group augmented with DBBM and collagen membrane ( | 0 | |
| 4/7 | 20–57 (41.09) | Posterior | Maxilla | 6 | 11 | 11 | 11 | 11 | Ridge preservation without flap advancement preserves more keratinized tissue and has less post-operative discomfort and swelling | NR | |
| 10/6 | 52.6 +/− 11.8 | Anterior & premolars | Maxilla/mandible | 6 | 16 | 16 | 16 | 16 | Alveolar ridge preservation with bioabsorbable membrane made of glycolide and lactide polymers showed significantly less loss of alveolar bone height, more internal socket bone fill, and less horizontal resorption of the alveolar bone ridge , compared to sites without membrane | 0 |
Fig. 2Risk of bias graph
Grading of network meta-analysis evidence
| Direct evidence | Indirect evidence | Network evidence | |||||
|---|---|---|---|---|---|---|---|
| Odds ratio (95% CI) | Quality of evidence | Odds ratio (95% CI) | Quality of evidence | Odds ratio (95% CI) | Quality of evidence | ||
| Horizontal | CM V CM:Cross | 0.42 (−2.65, 3.49) | Low | −1.09 (−4.79, 2.61) | Moderate | 1.51 (−3.30, 6.33) | Moderate |
| Con V Nonresorbable | −0.08 (−2.14, 1.97) | Low | 1.42 (−2.92, 5.78) | Moderate | −1.51 (−6.33, 3.30) | Moderate | |
| CM:Noncross V Auto | 0.04 (−0.93, 1.01) | Low | −3.56 (−4.66, −2.46) | High | 3.60 (2.13, 5.07) | High | |
| CM:Cross V Auto | −3.25 (−4.19, −2.30) | High | 0.35 (−0.77, 1.48) | Low | −3.60 (−5.07, −2.13) | High | |
| CM:Cross V CM:Noncross | 0.30 (−0.90, 1.51) | Low | −1.65 (−4.07, 0.76) | Moderate | 1.96 (−0.74, 4.66) | Moderate | |
| Nonresorbable V CM:Noncross | 0.79 (−1.96, 3.56) | Low | −0.71 (−4.66, 3.24) | Low | 1.51 (−3.30, 6.33) | Moderate | |
| Vertical | Con V CM:Cross | 0.36 (−2.30, 3.04) | Low | 0.46 (−2.26, 3.19) | Low | −0.09 (−3.19, 3.72) | Low |
| Con V Nonresorbable | −0.70 (−1.93, 0.53) | Low | −0.79 (−4.40, 2.81) | Low | 0.09 (−3.72, 3.91) | Low | |
| CM:Cross V CM:Noncross | 0.46 (−0.75, 1.68) | Low | 0.37 (−3.24, 3.99) | Low | 0.09 (−3.72, 3.91) | Low | |
| Nonresorbable V CM:Noncross | −0.70 (−2.80, 1.40) | Low | −0.60 (−3.79, 2.57) | Low | −0.09 (−3.91, 3.72) | Low | |
Fig. 3A Illustrates the network geometry plot for vertical dimensional changes. B Predictive interval and confidence interval plot for vertical dimensional changes. C The surface under the cumulative ranking curves (SUCRA) that expresses the percentage of effectiveness/safety each treatment has compared to an “ideal” treatment ranked always first without uncertainty. D Multidimensional scale ranking demonstrating the ranking of the sealing material in vertical dimensional outcomes based on dissimilarity
Fig. 4A Illustrates the network geometry plot for horizontal dimensional changes. B Predictive interval and confidence interval plot for horizontal dimensional changes. C The surface under the cumulative ranking curves (SUCRA) that expresses the percentage of effectiveness/safety each treatment has compared to an “ideal” treatment ranked always first without uncertainty. D Multidimensional scale ranking demonstrating the ranking of the sealing material in horizontal dimensional outcomes based on dissimilarity
Fig. 5A Illustrates the network geometry plot for histomorphometric changes. B The surface under the cumulative ranking curves (SUCRA) that expresses the percentage of effectiveness/safety each treatment has compared to an “ideal” treatment ranked always first without uncertainty. C Multidimensional scale ranking demonstrating the ranking of the sealing material in histomorphometric outcomes based on dissimilarity